About Apollo Sugar Clinics Limited
Data last updated: 06 January 2026
Apollo Sugar Clinics Limited is a public limited company based in Hyderabad, Telangana, India, a subsidiary of Apollo Health And Lifestyle Limited. It specialises in diabetes care and endocrinology clinics, a part of the broader healthcare sector. Incorporated on 11 June 2012, the company has been in operation for over 14 years.
Registered with ROC Hyderabad under CIN U85110TG2012PLC081384.
Capital: an authorised share capital of ₹4 Cr and a paid-up capital of ₹3.67 Cr. Formerly known as Apollo Clinics (Gujarat) Limited. It is led by directors including Chandra Sekhar Chivukula and Sriram Srinivasan Iyer.
Last AGM: 27 August 2025. Financial statements filed for year ended 31 March 2025. Office: 7 – 1 – 617/A 615 And 616 Imperial Towers 7Th Floor Ameerpet, Hyderabad, Telangana, India – 500038.
As per the financials filed for FY 2025, the company reported a revenue of ₹35.48 Cr, a growth of 3% compared to the previous year.
It operates as a subsidiary of Apollo Health And Lifestyle Limited.
The company is associated with 1 brand - Apollo Sugar.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website apollosugar.com.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media
-
Apps
-
Registered Address7 – 1 – 617/A 615 And 616 Imperial Towers 7Th Floor Ameerpet, Hyderabad, Telangana, India – 500038
-
IndustryHealthcare, Diabetes Care & Endocrinology Clinics
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Apollo Sugar Clinics Limited
Apollo Sugar Clinics Limited has one previous CIN (Corporate Identification Number): U85110AP2012PLC081384. The current CIN is U85110TG2012PLC081384, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U85110TG2012PLC081384 | Current |
| U85110AP2012PLC081384 | Previous |
Associated Brands with Apollo Sugar Clinics Limited
Apollo Sugar Clinics Limited operates one associated brand: Apollo Sugar. These brands represent Apollo Sugar Clinics Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Apollo Sugar runs a chain of clinics focused on diabetes management and treatment. | apollosugar.com |
Competitors & Alternatives of Apollo Sugar Clinics Limited
Brands and companies operating in the same space as Apollo Sugar Clinics Limited include Dr. Mohan’s Diabetes Specialities Centre, Lifespan, Cureos and 3 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Dr. Mohan’s Diabetes Specialities Centre
|
Chain of diabetes speciality centre | Chennai, India, India | 2012 |
Lifespan
|
Chain of diabetes & cardio metabolism clinics | Mumbai, India, India | 2011 |
Cureos
|
A chain of clinics focused on diabetes care is operated. | Delhi, India, India | 2020 |
DiabManage
|
Diabetes care is delivered via a chain of specialized clinics. | Bengaluru, India, India | 2017 |
Diabetes Free Forever
|
Provides programs for diabetes reversal, lifestyle management, and health consultations. | Pune, India, India | 2020 |
Samatvam
|
Online retailer specializing in Indian festive and Western fashion apparel. | Bengaluru, India, India | 1993 |
Business Activity of Apollo Sugar Clinics Limited
Apollo Sugar Clinics Limited is engaged in the principal business activity of hospital and medical care, with detailed activities including other hospital and medical care activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities | ********* |
Auditor Details of Apollo Sugar Clinics Limited
Apollo Sugar Clinics Limited is audited by Karra & Co. for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Karra & Co. | blur-value | blur-value | blur-value |
Board of Directors of Apollo Sugar Clinics Limited
Apollo Sugar Clinics Limited is currently managed by 4 directors, with 14 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chandra Sekhar Chivukula | Director | 15 Nov 2018 | 7 Years 7 Months | Current |
| Sriram Srinivasan Iyer | Director | 03 Nov 2023 | 2 Years 8 Months | Current |
|
Rachid Ayari
Also directs:
Sanofi India Limited
|
Director | 05 May 2025 | 1 Years 2 Months | Current |
| Madhu Sasidhar | Director | 30 Jul 2024 | 1 Years 11 Months | Current |
Financials of Apollo Sugar Clinics Limited FY 2025 filings available
Apollo Sugar Clinics Limited reported revenue of ₹35.48 Cr (up 3% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Shareholding Pattern of Apollo Sugar Clinics Limited
As of FY 2023, Apollo Sugar Clinics Limited's shareholding pattern shows 80.00% by promoters, 20.00% by public shareholders. The promoters hold a majority stake, indicating strong promoter control.
| Year | 2025 |
|---|---|
| Promoters | 33.19% |
| DII | 23.22% |
| FII | 18.28% |
| Public | 22.89% |
| Others | 2.42% |
Charges & Borrowings Apollo Sugar Clinics Limited
Apollo Sugar Clinics Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Apollo Sugar Clinics Limited
View historical data on people associated with Apollo Sugar Clinics Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Apollo Sugar Clinics Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Apollo Sugar Clinics Limited
GSTIN & GST Filing Data of Apollo Sugar Clinics Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Apollo Sugar Clinics Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Apollo Sugar Clinics Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Apollo Sugar Clinics Limited
MSME Payment Delays by Apollo Sugar Clinics Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Apollo Sugar Clinics Limited
Subsidiaries & Group Companies of Apollo Sugar Clinics Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Apollo Sugar Clinics Limited with ownership details.
MCA Filings & Documents of Apollo Sugar Clinics Limited
MCA Filings & Documents of Apollo Sugar Clinics Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Apollo Sugar Clinics Limited
Recent News on Apollo Sugar Clinics Limited
Frequently Asked Questions about Apollo Sugar Clinics Limited
Apollo Sugar Clinics Limited is an active public limited company in the healthcare sector based in Hyderabad, Telangana, India. It was incorporated on 11 June 2012 (14+ years old) and is registered under CIN U85110TG2012PLC081384.
Apollo Sugar Clinics Limited reported revenue of ₹35.48 Cr for FY 2025 (up 3.00% YoY).
The current directors of Apollo Sugar Clinics Limited are:
The primary industry of Apollo Sugar Clinics Limited is healthcare. The company specifically operates in diabetes care and endocrinology clinics. The company is currently active in this sector.
Apollo Sugar Clinics Limited can be reached at the registered office: 7 – 1 – 617A 615 And 616 Imperial Towers 7Th Floor Ameerpet, Hyderabad, Telangana, India – 500038, or through the website apollosugar.com.
The authorised capital is ₹4 Cr, and the paid-up capital is ₹3.67 Cr.